Spinal cord compression in prostate cancer: treatment outcome and prognostic factors
Robert Huddart(Institute of Cancer Research), D.P. Dearnaley(Royal Marsden NHS Foundation Trust), Matthew Law(UNSW Sydney), Lesley Meyer(Institute of Cancer Research), Balakrishnan Rajan(Regional Cancer Center, Thiruvananthapuram)
Cited by 75
Related Papers
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
|European Journal of Cancer|2005|576
Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer
|Journal of Clinical Oncology|2003|548
Estimates of benefits and harms of prophylactic use of aspirin in the general population
|Annals of Oncology|2014|388
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334